LexinFintech: Mixed Signals From Q4 Results

LexinFintech shows mixed 4Q25 results: asset quality and monetization efficiency deteriorated, while funding costs and user acquisition improved. Management guides to flattish loan growth for 1Q2026, citing policy uncertainty in China’s loan market. The analyst maintains a Hold rating after weighing these offsets.

Analysis

The microeconomics now look driven by a squeeze in unit economics: if originations cannot be meaningfully grown (management flagging conservatism), revenue must come from either higher take-rates or lower funding cost to protect margins — both are fungible and short-lived levers. In an environment where loan growth is flat, churn and LTV deterioration become the primary drivers of future revenue, so the path to earnings recovery requires either a sustained improvement in customer monetization or structural lowering of weighted funding costs.

Funding-cost improvements can be a durable competitive moat only if they arise from retail deposit switching or sticky low-cost funding sources; if the decline is from one-off wholesale windows or shorter-tenor swaps the margin tailwind will evaporate under any market stress. Similarly, apparent gains in user acquisition are ambiguous: efficiency gains (lower CAC or improved conversion) are positive, but customer-level monetization fading implies higher acquisition is being used to offset per-customer revenue shortfalls — a recipe for declining unit economics if vintage performance weakens.

Second-order competitive effects: better-capitalized fintechs and mid-sized banks will selectively tighten pricing to capture the top-quality cohorts, accelerating a bifurcation where weaker-originators are left with higher-risk vintages and outsized loss rates. Near-term catalysts that will re-rate the name are credit-flow datapoints (vintage NPLs over the next 2 quarters), PBOC/NTIA guidance on consumer lending windows, and any 1-2 quarter reversal in wholesale funding spreads; tail risks include a rapid wholesale funding repricing or abrupt regulatory tightening that forces higher provisions within one reporting cycle.

Key Decisions for Investors

• Maintain a neutral (Hold) equity stance on LX — reduce gross exposure by ~25% over the next 2 weeks and redeploy to higher-quality fintechs. R/R: limited near-term upside (12-month +20–30% if policy clarity returns) vs downside -20% in a credit/stability shock; use a hard 12% stop-loss on remaining position.
• Buy convexity: purchase Jan-2027 LX 15% OTM calls sized to 1–2% of portfolio notional and fund ~50% by selling Apr-2026 nearer-term calls (call-debit spread). Timeframe: enter within 3 months. R/R: capped premium loss with asymmetric 2–3x upside if regulatory/policy normalization restores loan growth and multiple expansion over 9–12 months.
• Relative-value pair: go long higher-underwriting-quality peer (e.g., QFIN) and short LX (equal notional) for 3–9 months to express quality-on-quality dispersion. Target 15%+ relative outperformance if credit vintage divergence widens; unwind if pair spread moves >20% against position or if borrower-level vintage performance converges.
• Hedge tail risk: buy 6–9 month LX puts (or equivalent CDS protection) sized to cover ~50% of equity exposure, with cost budgeted to 1–2% of portfolio. This limits portfolio drawdown from a sudden funding reprice or regulatory shock that could cause a >20% equity sell-off.